Page last updated: 2024-10-24

positive regulation of high-density lipoprotein particle assembly

Definition

Target type: biologicalprocess

Any process that increases the frequency, rate, or extent of high-density lipoprotein particle assembly. High-density lipoprotein particle assembly is the aggregation and arrangement of proteins and lipids to form a high-density lipoprotein particle. [GOC:BHF, GOC:dph, GOC:tb]

Positive regulation of high-density lipoprotein (HDL) particle assembly is a complex biological process that involves multiple steps and the coordinated action of various proteins and enzymes. This process is essential for maintaining healthy cholesterol levels and preventing cardiovascular disease.

**Here's a detailed description of the process:**

1. **Apolipoprotein A-I (ApoA-I) synthesis and secretion:** ApoA-I, the major protein component of HDL, is synthesized in the liver and small intestine. It is secreted into the bloodstream, where it interacts with other proteins and lipids.

2. **Formation of nascent HDL particles:** ApoA-I interacts with phospholipids and cholesterol, forming small discoidal nascent HDL particles. These particles are relatively poor in cholesterol and rich in phospholipids.

3. **Cholesterol acquisition and esterification:** Nascent HDL particles interact with peripheral tissues, such as the liver and adipose tissue, where they acquire cholesterol. The cholesterol is then transported to the liver by HDL. In the liver, the cholesterol is esterified by the enzyme lecithin-cholesterol acyltransferase (LCAT). This esterification reaction converts free cholesterol into cholesteryl esters, which are less soluble and can be stored in the core of HDL particles.

4. **HDL particle maturation:** As HDL particles acquire cholesterol and cholesteryl esters, they mature into larger, more spherical particles. This maturation process involves the transfer of cholesteryl esters from HDL to other lipoproteins, such as very low-density lipoprotein (VLDL) and low-density lipoprotein (LDL), through the action of cholesterol ester transfer protein (CETP).

5. **Reverse cholesterol transport:** Mature HDL particles transport cholesterol from peripheral tissues to the liver through the process of reverse cholesterol transport. In the liver, cholesterol is either excreted in bile or used for the synthesis of other steroid hormones.

**Regulation of HDL particle assembly:**

The process of HDL particle assembly is tightly regulated by various factors, including:

* **Genetic factors:** Variations in the genes encoding ApoA-I, LCAT, and CETP can affect HDL levels and particle size.
* **Environmental factors:** Factors such as diet, exercise, smoking, and alcohol consumption can influence HDL levels.
* **Hormones:** Hormones like estrogen and thyroid hormone can regulate HDL metabolism.

**Significance of HDL particle assembly:**

Positive regulation of HDL particle assembly is crucial for maintaining healthy cholesterol levels. HDL particles play a critical role in reverse cholesterol transport, removing excess cholesterol from peripheral tissues and preventing its accumulation in the arteries. This process helps to reduce the risk of atherosclerosis and cardiovascular disease.

**In summary, the positive regulation of HDL particle assembly is a complex process that involves multiple steps and the coordinated action of various proteins and enzymes. This process is essential for maintaining healthy cholesterol levels and preventing cardiovascular disease.**'
"

Proteins (1)

ProteinDefinitionTaxonomy
Oxysterols receptor LXR-betaAn oxysterols receptor LXR-beta that is encoded in the genome of human. [PRO:DNx, UniProtKB:P55055]Homo sapiens (human)

Compounds (25)

CompoundDefinitionClassesRoles
4-chlorophenol4-chlorophenol : A monochlorophenol substituted at the pare position by a chlorine atom.

4-chlorophenol: used as a root canal irrigant
monochlorophenol
butylparabenorganic molecular entity
3-chlorophenol3-chlorophenol : A monochlorophenol carrying the chloro substituent at position 3.monochlorophenol
4-phenoxyphenolphenoxyphenol
bis(4-oxyphenyl)sulfide4,4'-thiodiphenol: structure in first sourcephenols
1-deoxynojirimycin1-deoxy-nojirimycin: structure in first source

duvoglustat : An optically active form of 2-(hydroxymethyl)piperidine-3,4,5-triol having 2R,3R,4R,5S-configuration.
2-(hydroxymethyl)piperidine-3,4,5-triol;
piperidine alkaloid
anti-HIV agent;
anti-obesity agent;
bacterial metabolite;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
hepatoprotective agent;
hypoglycemic agent;
plant metabolite
betulinic acidhydroxy monocarboxylic acid;
pentacyclic triterpenoid
anti-HIV agent;
anti-inflammatory agent;
antimalarial;
antineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
plant metabolite
bexarotenebenzoic acids;
naphthalenes;
retinoid
antineoplastic agent
podocarpic acidpodocarpic acid : An abietane diterpenoid lacking the isopropyl substituent with an aromatic C-ring and a hydroxy group at the 12-position.

podocarpic acid: structure
abietane diterpenoid
cyanidincyanidin cation : An anthocyanidin cation that is flavylium substituted at positions 3, 3', 4', 5 and 7 by hydroxy groups.

cyanidin: RN given refers to parent cpd; structure
5-hydroxyanthocyanidinantioxidant;
metabolite;
neuroprotective agent
(22r)-22-hydroxycholesterol(22R)-22-hydroxycholesterol : An oxysterol that is the 22R-hydroxy derivative of cholesterol.22-hydroxy steroid;
3beta-hydroxy-Delta(5)-steroid;
oxysterol
2-chloro-1,4-dimethoxybenzenedimethoxybenzene
gw 3965GW 3965: a liver X receptor liganddiarylmethane
t0901317T0901317: an LXRalpha and LXRbeta agonist
alitretinoinAlitretinoin: A retinoid that is used for the treatment of chronic hand ECZEMA unresponsive to topical CORTICOSTEROIDS. It is also used to treat cutaneous lesions associated with AIDS-related KAPOSI SARCOMA.retinoic acidantineoplastic agent;
keratolytic drug;
metabolite;
retinoid X receptor agonist
24,25-epoxycholesterol24,25-epoxycholesterol: Rn given refers to (3alpha,5beta)-isomer; structure given in first source

24(S),25-epoxycholesterol : A 3beta-hydroxy-Delta(5)-steroid that is desmosterol in which the double bond at position 24-25 has been oxidised to the corresponding epoxide (the 24S diastereoisomer). It is an oxysterol agonist of the liver X receptor.
3beta-hydroxy-Delta(5)-steroid;
cholestanoid;
epoxy steroid
liver X receptor agonist
genistein7-hydroxyisoflavonesantineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
geroprotector;
human urinary metabolite;
phytoestrogen;
plant metabolite;
tyrosine kinase inhibitor
pregna-4,17-diene-3,16-dionepregna-4,17-diene-3,16-dione: steroid from guggulu extract; RN & N1 from C1 Form index; RN given refers to cpd without isomeric designation; structure in first source; antagonist of farnesoid X receptor3-hydroxy steroidandrogen
acanthoic acidacanthoic acid: from root bark of Acanthopanax koreanum; structure given in first source
3-chloro-4-(3-(7-propyl-3-trifluoromethyl-6-benzisoxazolyl)propylthio)phenylacetic acid
riccardin criccardin C: isolated from liverworts; functions as a liver X receptor (LXR)alpha agonist and an LXRbeta antagonist; structure in first source
bms 687453
way 2526232-(2-chloro-4-fluorobenzyl)-3-(4-fluorophenyl)-7-(trifluoromethyl)-2H-indazole: a partial LXR agonist
incb-018424nitrile;
pyrazoles;
pyrrolopyrimidine
antineoplastic agent;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
sr9238SR9238: liver-selective LXR inverse agonist that suppresses hepatic steatosis; structure in first source